1-deoxynojirimycin has been researched along with External Ophthalmoplegia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuisset, JM; Dobbelaere, D; Latour, P; Michaud, L; Sukno, S; Trauffler, A; Vallée, L | 1 |
| Klünemann, HH; Santosh, PJ; Sedel, F | 1 |
1 review(s) available for 1-deoxynojirimycin and External Ophthalmoplegia
| Article | Year |
|---|---|
Treatable metabolic psychoses that go undetected: what Niemann-Pick type C can teach us.
Topics: 1-Deoxynojirimycin; Age of Onset; Ataxia; Diagnosis, Differential; Disease Progression; Enzyme Inhibitors; Genetic Testing; Humans; Magnetic Resonance Spectroscopy; Niemann-Pick Disease, Type C; Ophthalmoplegia; Prevalence; Psychotic Disorders; Splenomegaly; Treatment Outcome | 2012 |
1 other study(ies) available for 1-deoxynojirimycin and External Ophthalmoplegia
| Article | Year |
|---|---|
Impact of miglustat on evolution of atypical presentation of late-infantile-onset Niemann-Pick disease type C with early cognitive impairment, behavioral dysfunction, epilepsy, ophthalmoplegia, and cerebellar involvement: a case report.
Topics: 1-Deoxynojirimycin; Adolescent; Carrier Proteins; Cerebellum; Cognition Disorders; Enzyme Inhibitors; Epilepsy; Humans; Intracellular Signaling Peptides and Proteins; Magnetic Resonance Imaging; Male; Membrane Glycoproteins; Mental Disorders; Mutation; Niemann-Pick C1 Protein; Niemann-Pick Disease, Type C; Ophthalmoplegia; Treatment Outcome | 2016 |